side effects of glp 1 long term Long-Term GLP-1 Medications: What You Should Know GLP-1 diabetes and weight-loss drug

This explains why the best formulations contain multiple peptide types

Iron metabolism and lipid peroxidation signaling are increasingly recognized as central mediators of ferroptosis

These products are not drugs, foods, cosmetics, diagnostic products, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

doi:10.1002/jcsm.13677 Sargeant JA, Henson J, King JA, Yates T, Khunti K, Davies MJ